openPR Logo
Press release

Apoptosis Market Growth, Trends and Forecast up to 2019

12-29-2017 09:14 AM CET | Health & Medicine

Press release from: Transparency Market Research

Apoptosis is a programmed natural process of cell death in the body which results from natural stimuli in order to protect against viral infection, unusual cell division and cells with damaged genetic material. However malfunctioning of apoptosis can trigger uncontrolled and non regulated cell death related to degenerative disorders such as Parkinson’s disease and Alzheimer’s. Defective apoptosis process has been one of the most common and leading causes for cancer wherein the affected cells instead of undergoing apoptosis continue to proliferate and mutate. Thus development of apoptosis modulating drugs has recently been witnessing spectacular growth in the treatment for cancer, CNS diseases, and chronic inflammation or autoimmunity disorders.

Some of the key players contributing to The Apoptosis Market include Abbott Laboratories, Inc., Aegera Therapeutics, Inc., Amgen, Inc., Bioniche Life Sciences, Inc., Chromo Therapeutics Limited, EntreMed, Inc., Genta, Inc., Infinity Pharmaceuticals, Inc., Novartis Limited, Pfizer, Inc., Xigen SA and Zentaris GmbH.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1653

Currently, North America dominates the global apoptosis market and is followed by Europe due to existence of huge potential for apoptosis modulating therapeutics and rising popularity of targeted cancer therapy. Emerging economies of Asia-Pacific, Latin America, Middle East and Africa are also expected to undergo rapid growth in the apoptosis market due to the rising incidences of cancer and unmet treatment needs in such developing regions.

The major factors driving the global market for apoptosis include continuous research and development in this field to achieve desired clinical results and thereby meet clinical needs in diseases such as cancer, focus on targeted cancer therapeutics and the need to overcome drug resistance.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=1653<ype=S

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Apoptosis Market Growth, Trends and Forecast up to 2019 here

News-ID: 879415 • Views: 217

More Releases from Transparency Market Research

Meningitis Diagnostic Testing Market Outlook, Trend, Growth and Share Estimation …
Meningitis Diagnostic Testing Market: Overview The global meningitis diagnostic testing market was valued over US$ 105.5 Mn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 3.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled "Meningitis Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025". The report suggests that rising demand for innovative
Metformin Hydrochloride API Market to Expand at a CAGR of ~5% from 2021 to 2031
Metformin Hydrochloride API Market: Introduction According to the report, the global metformin hydrochloride API market was valued at ~US$ 300 Mn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Metformin hydrochloride is primarily used in the treatment of diabetes. The prevalence of diabetes is expected to increase across the world due to change in lifestyle and factors such as malnutrition and genetic mutations.
Telehealth Market to Reach the Value of US$ 15 Bn by the End of 2028
Telehealth Market: Introduction According to the report, the global telehealth market was valued at US$ 7.8 Bn in 2020 and is projected to expand at a CAGR of 7% from 2021 to 2028. The global telehealth market has witnessed strong growth in the past few years. Telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19. Read Report Overview - https://www.transparencymarketresearch.com/telehealth-market.html The crisis presents an opportunity
Lyme Disease Treatment Market Growth Trends, Current Demand, and Development Rep …
Lyme Disease Treatment Market: Introduction According to the report, the global Lyme disease treatment market was valued at US$ 1.58 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. Increase in pet ownership, surge in awareness & adoption of veterinary care, and rise in healthcare expenditure on animals are anticipated to drive the global Lyme disease treatment market from 2021 to 2031.North America

All 5 Releases


More Releases for Apoptosis

Apoptosis Assays Market Size, Expectations & Growth Trends Highlighted until 202 …
According to the global Apoptosis Assays Market report published by Value Market Research, the market is expected to touch USD 6966.7 MN by 2025, with a CAGR of 10% growing from USD 3575 MN (by revenue) in 2018. This is a tailored made research report providing informative data and various critical aspects of the market such as market outlook, market share, growth, and trends. Further, the report also offers evidence-based
Apoptosis Regulator BAX Market 2021 Market Competitive Landscape Analysis
ReportsWeb.com published “Apoptosis Regulator BAX-Pipeline Review H2 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: According to the recently published report 'Apoptosis Regulator BAX - Pipeline Review, H1 2017'; Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) pipeline Target constitutes close to 6 molecules. Out of which
Research Delivers Insight into the Global Outlook for Apoptosis Market
Apoptosis is a programmed natural process of cell death in the body which results from natural stimuli in order to protect against viral infection, unusual cell division and cells with damaged genetic material. However malfunctioning of apoptosis can trigger uncontrolled and non regulated cell death related to degenerative disorders such as Parkinson’s disease and Alzheimer’s. Obtain Report Details @ http://www.transparencymarketresearch.com/apoptosis-market.html Defective apoptosis process has been one of the most common and leading
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis …
"Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Directs, Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2016, provides in depth analysis on Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor
Oncology Apoptosis Modulators Market Analysis, Trends, Forecast, 2016-2026
Apoptosis is genetically determined process of self-cell destruction of abnormal and damaged cells. If cells of a multicellular organisms are no longer needed, they commit suicide by activating an intracellular death program. It is a natural phenomenon and occurs via a tightly regulated complex signaling cascade. Inhibitor of apoptosis (IAP) protein family members are frequently overexpressed in cancer and contribute to tumor cell survival, chemo-resistance, disease progression, and poor prognosis.
2B Scientific Announce New Tool for Apoptosis, Flow Cytometry and Microscopy
2B Scientific, a leading UK distributor of life science reagents announce a new tool for scientists working in the field of apoptosis, pSIVA – Polarity Sensitive Indicator of Viability and Apoptosis from IMGENEX Corporation. Oxford, UK, January 17, 2012 - 2B Scientific, a leading UK distributor of life science reagents announce a new tool for scientists working in the field of apoptosis, pSIVA – Polarity Sensitive Indicator of Viability and Apoptosis